Basic Information
Basic information for SNHG14-225-78aa
Peptide Name SNHG14-225-78aa
Genome Position chr15:25225564-25225573,25226918-25227049,25228780-25228871[+]
Species Human
Peptide Sequence MGIDGDPGGKFVLGPLSLGQCQSARHPAPSALKLRTFLVPSAPALSSDGKPGGRLVLGPQAPGQCLSARCSASGALKL
Peptide Length 78
Unique No (SNHG14-203-78aa-1,SNHG14-207-78aa-1,SNHG14-228-78aa,SNHG14-244-78aa,SNHG14-273-78aa-1,SNHG14-285-78aa-1,SNHG14-294-78aa,SNHG14-295-78aa-1,SNHG14-317-78aa-1,SNHG14-326-78aa-1,SNHG14-327-78aa-1,SNHG14-329-78aa,SNHG14-331-78aa)
Grand Average of Hydropathicity 0.0705
Relative Molecular Mass 9124.14
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000652996;SNHG14-225
Transcript Length 3733
Coding Ability 0.506
DNA Sequence Corresponding to Peptide ATGGGTATAGATGGTGACCCCGGAGGAAAATTTGTGTTGGGCCCACTATCCCTGGGCCAATGTCAGTCAGCTAGGCACCCAGCCCCCAGTGCGCTGAAGCTCAGGACCTTCCTAGTGCCCTCGGCTCCTGCACTGAGCTCTGATGGTAAGCCTGGAGGAAGACTTGTGTTGGGCCCACAGGCCCCAGGCCAATGTCTGTCAGCCAGGTGCTCAGCCTCTGGTGCGCTGAAACTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :